(Q31966074)

5 July 2017

title

Effect of bisoprolol on QT dispersion in patients with congestive heart failure--the etiology-dependent response (English)

1 reference

5 July 2017

1 reference

congestive heart failure

1 reference

Peng DQ

1

1 reference

5 July 2017

Zhao SP

series ordinal

2

1 reference

5 July 2017

Chen Y

series ordinal

3

1 reference

5 July 2017

Li XP

series ordinal

4

1 reference

5 July 2017

publication date

1 February 2001

1 reference

International Journal of Cardiology

5 July 2017

published in

1 reference

5 July 2017

volume

77

1 reference

5 July 2017

issue

2-3

1 reference

5 July 2017

page(s)

141-8; discussion 148-9

1 reference

Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy

5 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900452-6

7 January 2021

Rationale for treatment of patients with chronic heart failure with adrenergic blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900452-6

7 January 2021

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900452-6

7 January 2021

A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900452-6

7 January 2021

QT dispersion and sudden unexpected death in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900452-6

7 January 2021

Electrocardiographic indexes of dispersion of ventricular repolarization: an isolated heart validation study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900452-6

7 January 2021

Dispersion of QT interval in patients with and without susceptibility to ventricular tachyarrhythmias after previous myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900452-6

7 January 2021

QT interval dispersion: a non-invasive marker of susceptibility to arrhythmia in patients with sustained ventricular arrhythmias?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900452-6

7 January 2021

Repolarization dispersion and sudden cardiac death in patients with impaired left ventricular function

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900452-6

7 January 2021

QT interval dispersion as a predictor of arrhythmic events in congestive heart failure. Importance of aetiology

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900452-6

7 January 2021

Ramipril reduces QT dispersion in patients with acute myocardial infarction and heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900452-6

7 January 2021

Enalapril reduces QTc dispersion in mild congestive heart failure secondary to coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900452-6

7 January 2021

QT dispersion in patients with chronic heart failure: beta blockers are associated with a reduction in QT dispersion

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900452-6

7 January 2021

Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute workshop

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900452-6

7 January 2021

Importance of lead selection in QT interval measurement

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900452-6

7 January 2021

Clinical significance of increased OT dispersion in the 12-lead standard ECG for arrhythmia risk prediction in dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900452-6

7 January 2021

Dispersion of ventricular repolarization and arrhythmic cardiac death in coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900452-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900452-6

1 reference

7 January 2021

QT dispersion and RR variations on 12-lead ECGs in patients with congestive heart failure secondary to idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900452-6

7 January 2021

Sensitivity and specificity of QTc dispersion for identification of risk of cardiac death in patients with peripheral vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900452-6

7 January 2021

Effects of bisoprolol on heart rate variability in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900452-6

7 January 2021

Effects of beta-blockade with bisoprolol on heart rate variability in advanced heart failure: analysis of scatterplots of R-R intervals at selected heart rates

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900452-6

7 January 2021

Effects of metoprolol on rest and exercise cardiac function and plasma catecholamines in chronic congestive heart failure secondary to ischemic or idiopathic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900452-6

7 January 2021

Effects of bucindolol on neurohormonal activation in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900452-6

7 January 2021

Can drug effects on mortality in heart failure be predicted by any surrogate measure?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900452-6

7 January 2021

Dispersion of the QT interval. A marker of therapeutic efficacy in the idiopathic long QT syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900452-6

7 January 2021

Effect of exercise-induced ischemia on QT interval dispersion

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900452-6

7 January 2021

Regression of left ventricular hypertrophy results in improvement of QT dispersion in patients with hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900452-6

7 January 2021

Beta-blocker dosages and mortality after myocardial infarction: data from a large health maintenance organization

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900452-6

7 January 2021

Relation of dispersion of QRS and QT in patients with advanced congestive heart failure to cardiac and sudden death mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900452-6

7 January 2021

Measurement and interpretation of QT dispersion.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900452-6

7 January 2021

QT dispersion from body surface ECG does not reflect the spatial dispersion of ventricular repolarization in sheep

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900452-6

7 January 2021

Assessment of QT interval and QT dispersion for prediction of all-cause and cardiovascular mortality in American Indians: The Strong Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900452-6

7 January 2021

10.1016/S0167-5273(00)00452-6

Identifiers

DOI

1 reference

5 July 2017

1 reference